Now showing items 1-2 of 2

    • Mortality Aacross two ART trials enrolling at ≤200 vs ≤350 CD4 cells uL in Kenya 

      Chung, Michael; Kiarie, James N; Yatich, Nelly; Njoroge, Julia; Kiptiness, Catherine; Sakr, Samah; John-Stewart, Grace; Frenkel, Lisa (University of Nairobi, 2015-02-26)
      Background: In 2011, Kenyan HIV treatment guidelines changed from initiating ART at a CD4 of ≤200 to ≤350 cells/uL. We compared 6-month mortality in 2 research cohorts, one enrolled before and one after the 2011 ART ...
    • Risk factors for airflow obstruction among HIV individuals in Nairobi, Kenya 

      Maleche-Obimbo, Elizabeth; Yatich, Nelly; Ndukwe, Lillian; Njoroge, Julia; Sakr, Sameh; Antouny, Neveen El; Attwa, Fr. Mena; Crothers, Kristina; Chung, Michael (University of Nairobi, 2015-02-26)
      Antiretroviral therapy (ART) and prolonged survival are shifting the spectrum of HIV-related pulmonary complications toward a greater burden of chronic lung disease (CLD). In developing countries, this impacts HIV+ ...